WallStSmart

QXO, Inc. (QXO)vsResideo Technologies Inc (REZI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Resideo Technologies Inc generates 9% more annual revenue ($7.47B vs $6.84B). QXO leads profitability with a -4.1% profit margin vs -7.0%. QXO earns a higher WallStSmart Score of 50/100 (C-).

QXO

Buy

50

out of 100

Grade: C-

Growth: 8.0Profit: 2.5Value: 3.0Quality: 4.8
Piotroski: 2/9

REZI

Hold

47

out of 100

Grade: D+

Growth: 6.7Profit: 4.0Value: 6.7Quality: 5.3
Piotroski: 2/9Altman Z: 1.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

QXOSignificantly Overvalued (-17.0%)

Margin of Safety

-17.0%

Fair Value

$23.12

Current Price

$18.76

$4.36 premium

UndervaluedFair: $23.12Overvalued
REZIUndervalued (+35.1%)

Margin of Safety

+35.1%

Fair Value

$56.06

Current Price

$39.75

$16.31 discount

UndervaluedFair: $56.06Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

QXO2 strengths · Avg: 10.0/10
Price/BookValuation
1.5x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
14725.0%10/10

Revenue surging 14725.0% year-over-year

REZI2 strengths · Avg: 9.0/10
EPS GrowthGrowth
928.0%10/10

Earnings expanding 928.0% YoY

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Areas to Watch

QXO4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
2.812/10

Expensive relative to growth rate

Return on EquityProfitability
-3.8%2/10

ROE of -3.8% — below average capital efficiency

REZI4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.0%4/10

2.0% revenue growth

Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-16.9%2/10

ROE of -16.9% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : QXO

The strongest argument for QXO centers on Price/Book, Revenue Growth. Revenue growth of 14725.0% demonstrates continued momentum.

Bull Case : REZI

The strongest argument for REZI centers on EPS Growth, Price/Book.

Bear Case : QXO

The primary concerns for QXO are EPS Growth, Piotroski F-Score, PEG Ratio.

Bear Case : REZI

The primary concerns for REZI are Revenue Growth, Altman Z-Score, Piotroski F-Score.

Key Dynamics to Monitor

QXO profiles as a hypergrowth stock while REZI is a turnaround play — different risk/reward profiles.

QXO carries more volatility with a beta of 2.37 — expect wider price swings.

QXO is growing revenue faster at 14725.0% — sustainability is the question.

REZI generates stronger free cash flow (262M), providing more financial flexibility.

Bottom Line

QXO scores higher overall (50/100 vs 47/100) and 14725.0% revenue growth. REZI offers better value entry with a 35.1% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

QXO, Inc.

INDUSTRIALS · INDUSTRIAL DISTRIBUTION · USA

QXO, Inc. is a business application, technology, and consulting company in North America. The company is headquartered in Greenwich, Connecticut.

Resideo Technologies Inc

INDUSTRIALS · INDUSTRIAL DISTRIBUTION · USA

Resideo Technologies, Inc. develops, manufactures and sells comfort, residential thermal and security solutions for commercial and residential end markets in the United States, Europe and internationally. The company is headquartered in Austin, Texas.

Want to dig deeper into these stocks?